NCT00676156 A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT00674934 Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS) Status UNKNOWN Phase PHASE1
NCT00670449 An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00666224 Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome Status COMPLETED Phase PHASE3
NCT00662649 Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00654927 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00649792 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial Status COMPLETED Phase PHASE3
NCT00648908 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial Status COMPLETED Phase PHASE3
NCT00644904 Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT00640328 Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Status COMPLETED Phase PHASE2
NCT00638196 Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS Status TERMINATED Phase PHASE1
NCT00630721 Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells Status COMPLETED Phase NA
NCT00630383 Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. Status WITHDRAWN Phase PHASE2
NCT00629642 Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00622700 Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis Status COMPLETED Phase PHASE3